Form 8-K - Current report:
SEC Accession No. 0001104659-24-127626
Filing Date
2024-12-11
Accepted
2024-12-11 16:25:34
Documents
37
Period of Report
2024-12-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2430782d1_8k.htm   iXBRL 8-K 26295
2 EXHIBIT 99.1 tm2430782d1_ex99-1.htm EX-99.1 20200
6 GRAPHIC tm2430782d1_ex99-1img001.jpg GRAPHIC 97098
7 GRAPHIC tm2430782d1_ex99-1img002.jpg GRAPHIC 195792
8 GRAPHIC tm2430782d1_ex99-1img003.jpg GRAPHIC 98551
9 GRAPHIC tm2430782d1_ex99-1img004.jpg GRAPHIC 197595
10 GRAPHIC tm2430782d1_ex99-1img005.jpg GRAPHIC 70412
11 GRAPHIC tm2430782d1_ex99-1img006.jpg GRAPHIC 89225
12 GRAPHIC tm2430782d1_ex99-1img007.jpg GRAPHIC 113403
13 GRAPHIC tm2430782d1_ex99-1img008.jpg GRAPHIC 115888
14 GRAPHIC tm2430782d1_ex99-1img009.jpg GRAPHIC 98783
15 GRAPHIC tm2430782d1_ex99-1img010.jpg GRAPHIC 102043
16 GRAPHIC tm2430782d1_ex99-1img011.jpg GRAPHIC 155977
17 GRAPHIC tm2430782d1_ex99-1img012.jpg GRAPHIC 81629
18 GRAPHIC tm2430782d1_ex99-1img013.jpg GRAPHIC 146819
19 GRAPHIC tm2430782d1_ex99-1img014.jpg GRAPHIC 110102
20 GRAPHIC tm2430782d1_ex99-1img015.jpg GRAPHIC 113776
21 GRAPHIC tm2430782d1_ex99-1img016.jpg GRAPHIC 70217
22 GRAPHIC tm2430782d1_ex99-1img017.jpg GRAPHIC 90646
23 GRAPHIC tm2430782d1_ex99-1img018.jpg GRAPHIC 76152
24 GRAPHIC tm2430782d1_ex99-1img019.jpg GRAPHIC 125789
25 GRAPHIC tm2430782d1_ex99-1img020.jpg GRAPHIC 125402
26 GRAPHIC tm2430782d1_ex99-1img021.jpg GRAPHIC 117782
27 GRAPHIC tm2430782d1_ex99-1img023.jpg GRAPHIC 356837
28 GRAPHIC tm2430782d1_ex99-1img024.jpg GRAPHIC 82928
  Complete submission text file 0001104659-24-127626.txt   4133387

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA anvs-20241211.xsd EX-101.SCH 3021
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE anvs-20241211_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anvs-20241211_pre.xml EX-101.PRE 22363
39 EXTRACTED XBRL INSTANCE DOCUMENT tm2430782d1_8k_htm.xml XML 3791
Mailing Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355 484-875-3192
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39202 | Film No.: 241541826
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)